1. Home
  2. SNOA vs DGLY Comparison

SNOA vs DGLY Comparison

Compare SNOA & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • DGLY
  • Stock Information
  • Founded
  • SNOA 1999
  • DGLY 2004
  • Country
  • SNOA United States
  • DGLY United States
  • Employees
  • SNOA N/A
  • DGLY N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • SNOA Health Care
  • DGLY Technology
  • Exchange
  • SNOA Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • SNOA 3.7M
  • DGLY 3.5M
  • IPO Year
  • SNOA 2007
  • DGLY N/A
  • Fundamental
  • Price
  • SNOA $2.53
  • DGLY $0.56
  • Analyst Decision
  • SNOA
  • DGLY
  • Analyst Count
  • SNOA 0
  • DGLY 0
  • Target Price
  • SNOA N/A
  • DGLY N/A
  • AVG Volume (30 Days)
  • SNOA 366.2K
  • DGLY 186.6K
  • Earning Date
  • SNOA 02-06-2025
  • DGLY 12-27-2024
  • Dividend Yield
  • SNOA N/A
  • DGLY N/A
  • EPS Growth
  • SNOA N/A
  • DGLY N/A
  • EPS
  • SNOA N/A
  • DGLY N/A
  • Revenue
  • SNOA $13,547,000.00
  • DGLY $23,417,110.00
  • Revenue This Year
  • SNOA $23.89
  • DGLY $22.14
  • Revenue Next Year
  • SNOA $25.45
  • DGLY N/A
  • P/E Ratio
  • SNOA N/A
  • DGLY N/A
  • Revenue Growth
  • SNOA 11.81
  • DGLY N/A
  • 52 Week Low
  • SNOA $2.44
  • DGLY $0.51
  • 52 Week High
  • SNOA $9.40
  • DGLY $3.29
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 40.15
  • DGLY 33.18
  • Support Level
  • SNOA $2.61
  • DGLY $0.51
  • Resistance Level
  • SNOA $3.25
  • DGLY $0.78
  • Average True Range (ATR)
  • SNOA 0.21
  • DGLY 0.10
  • MACD
  • SNOA -0.02
  • DGLY -0.01
  • Stochastic Oscillator
  • SNOA 11.11
  • DGLY 14.17

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: